be_ixf;ym_202110 d_16; ct_50

Clinical Research Studies

Improving the health of our patients through groundbreaking clinical research.

The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.

Current Dermatology Clinical Trials

Study: Acne

Cutera Acne - IRB approved ad

Purpose: To evaluate the safety and efficacy of the investigational Cutera® 1726 nm laser system (also referred to as ‘Alice’) for the treatment of mild to severe acne vulgaris. Subjects will receive three 1726 nm laser treatments at 3 week intervals. Follow-up visits will occur at approximately 10 days post each treatment (via phone) and at 4-, 12-, 26- and 52-weeks post-final treatment.

Qualifications:

  • Female and male subjects, ages 16 to 60 years
  • Fitzpatrick skin types I-IV with mild, moderate, or severe acne vulgaris

Duration: Approx. 18 months
Location: Hackensack, NJ
Compensation: $325
Referral Fee: Help someone you know struggling with acne by referring them. Your referral will qualify you for a $200 bonus.

Interested in participating in our clinical research study? Please click here.


Study: Vitiligo Trial

Purpose: Vitiligo is a skin condition in which there is a loss of color (referred to as “depigmentation”) from areas of skin. This results in uneven white patches that have no pigment, but the skin feels like normal. The purpose of the study you are being asked to participate in is to evaluate the safety and effectiveness of the RECELL® Device when used for repigmentation of stable vitiligo. Stable vitiligo means that the areas affected by loss of pigment have been unchanged for at least the last 12 months. The study will evaluate the effect of using RECELL for repigmentation.

Qualifications:

  • Male and Females, 18 years or older
  • Diagnosed with Focal, segmental or generalized (i.e., nonsegmental) vitiligo photographically documented as stable (No new lesions within the previous 12 months)

Duration: Approx. 52 weeks
Location: Hackensack, NJ
Compensation: If all visits are kept, up to $1350 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Alopecia Areata

Purpose: This research study will look at two different doses of CTP-543 compared to placebo (looks like the study drug, but does not contain active ingredients) when given to research subjects with alopecia areata (sudden hair loss) twice-daily for 24 weeks. The main purpose is to determine if CTP-543 will result in hair regrowth, and to see if taking CTP-543 is safe.

Qualifications:

  • Male and Females, ages 18 to 65 inclusive
  • Definitive diagnosis of alopecia areata with a current episode of scalp hair loss lasting at least 6 months and not exceeding 10 years at the time of Screening. Total disease duration greater than 10 years is permitted.
  • At least 50% scalp hair loss, as defined by a SALT score ≥50, at Screening and Baseline.

Duration: Approx. 28 weeks
Location: Hackensack, NJ
Compensation: If all visits are kept, up to $500 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Atopic Dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.

Qualifications:

  • Male and Females, ages 18 to 55 years of age
  • Have moderate to severe atopic dermatitis for at least 1 year
  • Failure to improve with topical prescriptions

Duration: 32 weeks/ visiting doctors office 7 to 11 times
Locations: Hackensack, NJ
Compensation: If all visits are kept, up to $600 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Treatment to Lift Lax Skin

Purpose: To evaluate the safety and efficacy of Sofwave treatment to lift lax tissue in the submental and neck zones and to lift the eyebrow. This study is a two-arm study. Eligible patients will receive 2-4 face and/or neck and/or submental or “off the face” (abdomen, or arms, or thighs, or Décolleté) treatments (per PI discretion, 2-12 weeks apart) using the Sofwave System. Follow up visits will be conducted at 3 and 6 months post final treatment.

Qualifications:

  • Healthy female and male subjects between the ages 35-80.
  • Non-Smoker
  • Fitzpatrick skin type I-VI.
  • Desire to lift loose hanging skin in the neck and submental and/or to lift the brows.

Duration: Approx. 6-8 months
Location: Hackensack, NJ
Compensation: $160

Interested in participating in our clinical research study? Please click here.


Study: Microneedling

Purpose: A clinical research study to test the effectiveness of the Collagen P.I.N. microneedling device in improving the appearance of moderate to severe non-facial scars. Subjects of will be required to complete four (4) treatment visits and one (1) follow-up visit.

Qualifications:

  • Adults 22 years of age or older
  • At least 1 non-facial trauma or surgical scar present for at least 6 months

Duration: Approx. 22 weeks
Location: Hackensack, NJ
Compensation: $250

Interested in participating in our clinical research study? Please click here.


Study: Prurigo Nodularis

Purpose: To evaluate the effect of NAL ER (oral tablet) on itch as assessed by the percentage of Responders (‘response’ is defined as a ≥ 4-point reduction in the 7-day average Worst Itch – Numerical Rating Scale [WI-NRS]).

Qualifications:

  • Male and Females, 18 years or older
  • Must have PN on 2 areas of the body

Duration: Up to 52 weeks
Location: Hackensack, NJ
Compensation: TBD

Interested in participating in our clinical research study? Please click here.


Study: Naso-Labial Folds Volume Restoration

Purpose: To evaluate the effects of RENUVA® HD Treatment on human skin quality and nasolabial fold volume restoration. Subject with moderate deep wrinkles to very deep wrinkles of the nasolabial folds will receive 1 treatment using Renuva on the right and left side of the face and the right infra auricular area (behind/below their ear). Subject will undergo 5 biopsy procedures of the right treated infra auricular area: pre-treatment, day 30, day 60, day 90, and day 180 after treatment to evaluate if Renuva induces Collagen and Elastin production.

Qualifications:

  • Adults aged 30 – 65
  • Healthy female or male volunteers with moderate deep wrinkles to very deep wrinkles of the nasolabial folds.

Duration: Approx. 6 months
Location: Hackensack, NJ
Compensation: $375

Interested in participating in our clinical research study? Please click here.


Study: Injectable Treatment to Treat Cutaneous Squamous Cell Carcinoma

Purpose: The purpose of this trial is to evaluate the safety, tolerability, and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma in situskin cancer(isSCC).

Qualifications:

  • Male and Females, 18 years or older5
  • Current diagnosis of SCC

Duration: Up to 14 weeks
Location: Hackensack, NJ
Compensation: Up to $785

Interested in participating in our clinical research study? Please click here.


Study: Injectable Treatment to Treat Keloids

Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.

Qualifications:

  • Male and Females, 18 – 60 years old
  • Have at least one keloid scar present for at least one year on the upper body, arms, or legs

Duration: 54 weeks
Location: Hackensack, NJ
Compensation: Up to $1,100 if all study visits are completed

Interested in participating in our clinical research study? Please click here.

Interested in participating in our clinical research study?

Please click here


What to expect during a clinical trial:

  • Access to new investigational treatments before they are made widely available
  • Financial compensation for participation
  • An opportunity to contribute to the advancement of medical science through research
  • Study visits conducted by a trained and dedicated research team
  • Adherence to strict industry and safety standards.
  • Evaluations performed by one of our certified providers

To learn more contact: Diana Aranzazu, research@schweigerderm.com, 609-219-5621

About Schweiger Dermatology Group

Schweiger Dermatology Group was founded to help make excellent dermatology care accessible throughout the Northeast. In 2010, Dr. Eric Schweiger started the practice with a single location in Midtown Manhattan. When he saw the need for high-quality dermatology care that did not require weeks or months of waiting to see a qualified provider, his vision of a multi-location practice was born.

Back to Top
>

Receive skincare tips, news and special offers!

Field marked with asterisk (*) is mandatory.